Early impairment of coronary microvascular perfusion capacity in rats on a high fat diet by unknown
van Haare et al. Cardiovasc Diabetol  (2015) 14:150 
DOI 10.1186/s12933-015-0312-2
ORIGINAL INVESTIGATION
Early impairment of coronary 
microvascular perfusion capacity in rats  
on a high fat diet
Judith van Haare1, M. Eline Kooi2, Hans Vink1, Mark J. Post1, Jurgen W. G. E. van Teeffelen1, Jos Slenter2, 
Chantal Munts1, Hanneke Cobelens1, Gustav J. Strijkers4, Dennis Koehn5 and Marc van Bilsen1,3*
Abstract 
Background: It remains to be established if, and to what extent, the coronary microcirculation becomes compro-
mised during the development of obesity and insulin resistance. Recent studies suggest that changes in endothelial 
glycocalyx properties contribute to microvascular dysfunction under (pre-)diabetic conditions. Accordingly, early 
effects of diet-induced obesity on myocardial perfusion and function were studied in rats under baseline and hyper-
aemic conditions.
Methods: Rats were fed a high fat diet (HFD) for 6 weeks and myocardial microvascular perfusion was determined 
using first-pass perfusion MRI before and after adenosine infusion. The effect of HFD on microcirculatory properties 
was also assessed by sidestream darkfield (SDF) imaging of the gastrocnemius muscle.
Results: HFD-fed rats developed central obesity and insulin sensitivity was reduced as evidenced by the marked 
reduction in insulin-induced phosphorylation of Akt in both cardiac and gastrocnemius muscle. Early diet-induced 
obesity did not lead to hypertension or cardiac hypertrophic remodeling. In chow-fed, control rats a robust increase in 
cardiac microvascular perfusion was observed upon adenosine infusion (+40 %; p < 0.05). In contrast, the adenosine 
response was abrogated in rats on a HFD (+8 %; N.S.). HFD neither resulted in rarefaction or loss of glycocalyx integrity 
in skeletal muscle, nor reduced staining intensity of the glycocalyx of cardiac capillaries.
Conclusions: Alterations in coronary microcirculatory function as assessed by first-pass perfusion MRI represent one 
of the earliest obesity-related cardiac adaptations that can be assessed non-invasively. In this early stage of insulin 
resistance, disturbances in glycocalyx barrier properties appeared not to contribute to the observed changes in coro-
nary microvascular function.
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Background
Obesity is one of today’s major worldwide health prob-
lems and is a primary risk factor for type 2 diabetes and 
cardiovascular disease [1, 2]. In particular, abdominal 
obesity is associated with insulin resistance [3, 4]. Sev-
eral studies reported altered microvascular function 
and microvascular remodeling in the skin and skeletal 
muscle of obese subjects [5–7]. The changes in micro-
vascular properties observed under these conditions 
include impaired vasomotor activity, increased perme-
ability, reduced capillary recruitment and rarefaction 
[8–12]. More recent studies also point to abnormalities 
in glycocalyx function contributing to the microvascular 
dysfunction [13–15]. The endothelial glycocalyx contrib-
utes to the vasculoprotective effects of the vessel wall by 
mediating nitric oxide (NO) release, by acting as a per-
meability barrier, and by inhibiting platelet and leukocyte 
adhesion [16–18]. Indeed, a reduction of microvascular 
glycocalyx dimensions has been observed in patients 
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with increased cardiovascular risk [15]. In mice with diet-
induced obesity, microcirculatory glycocalyx dysfunction 
in skeletal muscle was observed [13]. To date information 
on whether the abnormalities in microvascular function 
in obese and insulin resistant subjects also involve the 
coronary microcirculation is scarce and often conflicting 
[19–25]. As far as the glycocalyx of the coronary circula-
tion is concerned, it has been shown that the glycocalyx is 
shedded in case of highly injurious conditions like myo-
cardial ischemia/reperfusion [26]. If glycocalyx integrity 
also gets perturbed under less injurious conditions, as 
evoked by diet-induced obesity, is entirely unknown.
Accordingly, in the present study it was explored if 
diet-induced obesity affects cardiac function and coro-
nary microvascular perfusion at an early stage, and if 
so, if this was linked to compromised glycocalyx func-
tion. Obesity was induced by challenging rats with a high 
fat diet (HFD; 60 % kcal fat) for 6 weeks [14, 27, 28] and 
insulin resistance was monitored by measuring myo-
cardial Akt phosphorylation. Myocardial perfusion was 
determined under baseline and hyperaemic conditions 
as induced by adenosine, using first-pass perfusion MRI, 
a non-invasive method that is increasingly applied in the 
clinic for evaluation of the myocardial perfusion status 
[29, 30]. Cardiac function was assessed using cine MRI. 
To evaluate the effects of HFD on glycocalyx properties 
more directly, the microcirculation of the gastrocnemius 
was visualised with a Sidestream Dark-Field (SDF) cam-
era in the same animals. HFD-induced changes in cardiac 
phenotype were assessed by qPCR and (immuno)histo-
logical analysis.
Collectively, the present findings show that the aden-
osine-evoked increase in myocardial microvascular per-
fusion is blunted in diet-induced obese rats, mainly due 
to an already increased basal perfusion. We found no 
evidence that, in this early stage of insulin resistance, 
changes in glycocalyx properties contributed signifi-




All animal experiments were performed according to a 
protocol approved by the Animal Ethics Care and Use 
committee of Maastricht University (AEC protocol num-
ber: 2010-122). 10 weeks old male Wistar Hannover rats 
(n  =  18; body weight 300–324  g; Harlan Laboratories, 
Horst, The Netherlands) were housed in standard cages 
with 2 rats per cage, in a temperature-controlled room 
(~23  °C; 40–60  % humidity) under a 12/12  h light/dark 
cycle at the animal facility of Maastricht University. Rats 
received standard chow (Ssniff GmbH, Soest, Germany, 
containing on caloric basis 9 % fat, 58 % carbohydrates, 
and 33 % protein) for 6 weeks (n = 9) or HFD (D12492; 
Research Diets, New Brunswick, containing on caloric 
basis 60 % fat, 20 % carbohydrate, and 20 % protein), also 
for 6 weeks (n = 9). All animals received diet and water 
ad libitum.
Every week, body weight was determined and blood 
pressure was measured by the tail cuff method using a 
CODA non-invasive blood pressure monitoring system 
(Kent Scientific, Torrington, CT). Blood was sampled 
from the saphenous vein in the non-fasted, conscious 
animals to determine glucose and plasma insulin levels. 
Blood glucose (~5 µl) was measured with a glucose meter 
(Ascencia Contour, Bayer, Mijdrecht, The Netherlands). 
Blood was collected using 75  µl glass capillary tubes 
(Hirschmann, Eberstadt, Germany). The capillary tubes 
were centrifuged, plasma hematocrit levels were deter-
mined (MSE, micro-haematocrit reader), and plasma was 
collected to measure plasma insulin levels with an Ultra-
sensitive Insulin ELISA kit according to the manufactur-
er’s protocol (ALPCO Diagnostics, Salem, NH).
A separate set of control rats (n  =  9) and HFD rats 
(n = 9) was used to perform an intravenous insulin tol-
erance test (AEC protocol number: 2011-139). The rats 
were housed under the same conditions as described 
before.
MR imaging
At the day of experiment, non-fasted rats were subcu-
taneously injected with 0.05  mg/kg of buprenorphine 
about 30 min before surgery, and were anesthetized with 
isoflurane (induction chamber: 4.5 % isoflurane and 1 % 
oxygen, during experiment: 2 % isoflurane and 0.4 % oxy-
gen). The animal was put in a prone position and body 
temperature was maintained at  ~37  °C by the use of a 
heating pad. During anesthesia, a cannula was inserted in 
the jugular vein for infusion of adenosine for stress meas-
urements. For the infusion of the contrast agent for MRI, 
both left and right femoral vein were cannulated. After 
surgery, the anesthetized rats were positioned prone and 
horizontally in an animal holder on a heating pad in the 
magnet. Body temperature was monitored by a rectal 
probe. ECG electrodes were positioned on the right front 
leg and left hind leg and connected to an MR compatible 
small animal monitoring system (SA Instruments, Stony 
Brook, NY, USA). Respiratory rate was continuously 
monitored. Magnetic resonance imaging to determine 
myocardial function and perfusion was performed dur-
ing baseline conditions and during intravenous adeno-
sine infusion (3 mg/ml; 1.5 ml/h).
Cine MRI
Magnetic resonance imaging was performed on a 7.0 
Tesla Bruker Biospec 70/30 USR animal scanner (Bruker 
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Biospin, Ettlingen, Germany) equipped with a quadra-
ture volume coil. Sequential multislice short-axis cine 
MRI was performed to assess systolic function of the left 
ventricle. First, a bright blood cine MR image with 10 
cardiac phases was recorded in 4-chamber view (4CH) 
using a retrospectively self-gated protocol (IntraGate, 
Bruker Biospin) as described previously [31]. The fol-
lowing acquisition parameters were used: pulse repeti-
tion time (TR) = 8 ms, echo time (TE) = 2.95 ms and flip 
angle = 10°. The acquired field of view was 50 × 50 mm2 
with an acquired 256 × 256 matrix size with an imaging 
time of  ~5  min. Perpendicular to the 4CH view, a long 
axis view (LA) was acquired using the same self-gated 
protocol. This imaging slice was oriented as a plane 
through the mitral valve and the apex. Perpendicular to 
this LA and 4CH view, two short axis slices (SA) were 
positioned just below the mitral valve and just above the 
start of the papillary muscles. For both slices, the same 
self-gated protocol was used.
Myocardial first‑pass perfusion MR imaging
A time-series of 300 short-axis images was acquired 
using a first-pass perfusion sequence, so that the first 
pass of the contrast agent through the heart was cap-
tured. A bolus of 150 µl Gadobutrol (200 mM; Gadovist, 
Bayer HealthCare, Berlin, Germany) was injected during 
the 15th time phase in the femoral vein, while scanning 
continued. For the mid-ventricular, short-axis first-pass 
perfusion images, an ECG-triggered, segmented satu-
ration-recovery FISP sequence was used as described 
in detail elsewhere [32, 33]. A temporal resolution was 
reached of one image per four heartbeats. The prospec-
tive trigger delay δSAT with respect to the R-peak of the 
ECG-signal was adjusted to the heart rate and cho-
sen such that the effective saturation time TSAT was 
between 20 and 30  ms. The segment acquisition time 
TACQ was 25.76  ms. Additionally, the following acquisi-
tion parameters were used: TR = 1.61 ms, TE = 0.8 ms, 
field of view = 6 × 6 cm2, acquisition matrix = 64 × 64 
(4 segments, acquired over four consecutive heart beats), 
slice thickness  =  3  mm, 0.3  ms Gauss excitation pulse 
(α =  15°; BW =  9133  Hz) and a 2  ms Gauss saturation 
pulse (α  =  90°; BW  =  1370  Hz). Reconstructed pixel 
size was 469 × 469 µm2 after zero-filling to 128 ×  128. 
Centric k-space filling was performed to ensure that low 
spatial frequency information was least influenced by 
cardiac motion.
Imaging of skeletal muscle microcirculation
To determine the effect of HFD on glycocalyx barrier 
properties, the microcirculation of the gastrocnemius 
was visualised with a Sidestream Dark-Field (SDF) cam-
era after the first-pass perfusion MR imaging. Three 
measurements were performed in each rat to visualise 
the microvessels on different positions in the gastrocne-
mius. The SDF camera is equipped with a 5x magnifying 
objective lens system-containing probe, imaging the red 
blood cells (RBCs) in the tissue-embedded microcircula-
tion using green pulsed LED ring illumination [14, 34]. A 
micromanipulator was used for holding the SDF camera 
at the same position. Dimensions of the endothelial gly-
cocalyx were estimated by imaging the microcirculation 
in the gastrocnemius using the SDF camera with inte-
grated software (GlycoCheck BV, Maastricht, The Neth-
erlands) for automatic analysis of the video recordings as 
previously described [35, 36].
After imaging of the muscle microcirculation, when the 
animal is still under anesthesia, the rat was sacrificed by 
cutting the diaphragm, and gastrocnemius were removed 
and immediately cut in two parts for fixation in a 4  % 
formaldehyde solution and in Tissue-Tek (O.C.T. Com-
pound) for cryostat sectioning. The heart was also fixated 
for histological analysis. For only four control rats and 
four rats on HFD, heart weight was determined, even as 
epidydimal and perirenal fat.
Insulin tolerance test
After an overnight fast (10–12 h) an intravenous insulin 
tolerance test (IVITT) was performed in a separate set of 
chow-fed (n = 9) and HFD-fed rats (n = 9), to measure 
insulin-mediated glucose disposal. After analgesia and 
anesthesia (isoflurane 2 %) the femoral vein was cannu-
lated. Baseline blood glucose concentration was meas-
ured via tail bleeding and 2 glass capillaries of blood were 
taken for baseline plasma insulin measurements. Next, 
rats received a bolus of glucose (1 g/kg, 0.5 g/ml, i.v.) to 
avoid the development of hypoglycemia after adminis-
tering the bolus of insulin 30 min later (0.5 U/kg; 0.5 U/
ml). Blood glucose and plasma insulin were measured as 
described above at the indicated time points. Rats were 
sacrificed before glucose infusion, and 5 min and 30 min 
after insulin infusion. Heart, gastrocnemius and soleus 
muscle were isolated, instantly frozen in liquid nitrogen, 
and stored at −80 °C.
Western blotting
Tissues were homogenized, sonicated, and centrifuged in 
ice-cold SET buffer in the presence of phosphatase inhib-
itor (PhosSTOP, Roche) and protease inhibitor (Com-
plete, Roche). Protein concentrations of the supernatants 
were determined using a BCA Protein Assay (Micro BCA 
Protein Assay Kit, Pierce). After electrophoresis samples 
were transferred to a PVDF membrane (Bio-Rad) and, 
after washing, incubated with a phospho-Akt(Ser473) 
rabbit antibody (Cell Signalling Technology, Beverly MA) 
and subsequently with anti-rabbit secondary antibody 
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(Cell Signalling Technology) and with HRP substrate 
(SuperSignal West Femto Chemiluminescent Substrate, 
Pierce). After stripping (Restore Western Blot Strip-
ping Buffer, Pierce) membranes were incubated with an 
Akt antibody (Cell Signalling Technology). Chemilumi-
nescent signals were detected and quantified using the 
ChemiDoc XRS system (Bio-Rad). The ratios of pAkt/Akt 
were used to assess differences in insulin signalling.
Data analysis
Cine MRI
All images were analysed in MRIcro. The end-diastolic 
volumes (EDV) and end-systolic volume (ESV) of the 
left ventricle were considered the largest and the small-
est areas, respectively, of the LV cavity in each slice. For 
the analysis of cine MRI, the window width and level 
were manually adjusted to recognize the internal ven-
tricular morphologic characteristics [31]. For the meas-
urements of LV volumes, the whole cavity was manually 
selected in MRIcro. The papillary muscle was excluded 
from the LV volume during analysis. Length (L) of the 
LV on the LA view was defined as the longest distance 
from the apex to the valves. To calculate the left ven-
tricular volumes (LVV), the modified simpson rule (SR) 
was used as described before [31]. Briefly, LVV = Am × 
L/3 + (Am + Aρ)/2 × L/3 + 1/3 × Aρ × L/3. (Am, cross-
sectional area of the LV cavity in the SA plane, ~1–2 mm 
below the mitral valve; Aρ, cross-sectional area of the LV 
cavity in the SA plane, approximately at the base of the 
papillary muscles).
Also the first derivative of LV volume over time (dV/dt) 
during the cardiac cycle was calculated for all rats. The 
change in volume and time during each of the cardiac 
cycle phase transitions of the 10 time frames was deter-
mined, during baseline and adenosine infusion [37].
Wall thickness of the left ventricle is calculated using 
the CAAS MRV FARM software package (version 2.1, Pie 
Medical Imaging, Maastricht, The Netherlands). In the 
short axis slice just below the mitral valve, the end-dias-
tolic and end-systolic phase was marked. The endocardial 
and epicardial borders were manually delineated. Wall 
thickness is determined for the septum and the free wall, 
calculating the length of a segment between the epicar-
dial and endocardial contours in the systolic and diastolic 
phase. For each of the segments, the distance between 
two contours is given in micrometers.
MR Perfusion analysis
In the first-pass perfusion data sets, manual segmenta-
tions were performed within the CAAS MRV FARM 
software package (version 2.1, Pie Medical Imaging, 
Maastricht, The Netherlands). Endocardial and epicardial 
borders were manually delineated. Contours were drawn 
in one frame of the slice and were copied automatically 
to the other, in total 300, frames. Contour edits were also 
copied to all frames in the slice and a visual check was 
performed to examine if the contours fit in all the images 
of the 300 time frames. In case the contours did not fit 
in an image, the contours were adjusted in that separate 
image. The LV cavity, or blood pool, was detected auto-
matically if an endocardial contour was available. Papil-
lary muscles were excluded from the LV cavity. To avoid 
partial volume effects within the myocardial and LV cav-
ity regions of interests (ROI’s), a margin of 1 pixel was 
kept from the epicard and endocard contours.
After segmentation, signal intensity (SI)-time curves 
were obtained for the LV cavity and the myocardium. The 
relative upslope was calculated by dividing the maximum 
upslope of the myocardium by the maximum upslope of 
the LV cavity curve. The myocardium was divided in 6 
segments, for each segment the relative upslope was cal-
culated. For data analysis, the mean of these 6 segments 
was used. The upslope was calculated within a kernel of 
2–3 time points for the LV cavity and 4–5 time points for 
the myocardium. The number of points within the kernel 
used for upslope calculations (e.g. 2–3 for the LV cavity 
and 4–5 for the myocardium) was adjusted for each sig-
nal intensity-time curve based on a visual inspection to 
acquire the best fit of the upslope.
Imaging of skeletal muscle microcirculation
During video recording, the software automatically identi-
fies all visible microvessels with a diameter between 5 and 
25 µm and measurement sites perpendicular to the vessel 
direction were selected every 10  µm along the length of 
each microvessel (Fig.  1a, b). Data acquisition automati-
cally started when image quality was within acceptable 
range, i.e. good red blood cell (RBC) and background con-
trast, in focus and without movement of the imaging unit. 
When data on a minimum number of 3000 measurement 
sites was obtained, data acquisition automatically stopped. 
Average duration of data acquisition was ~5 min. Movies 
consisted of 40 consecutive frames. In each frame, at each 
measurement site a total of 21 parallel (every ±  0.5  µm) 
intensity profiles were plotted. The RBC column width 
was automatically determined at each line for all 40 con-
secutive frames in a movie, revealing a total of 840 RBC 
column width measurements at a single measurement (21 
profiles × 40 frames) [14]. RBC filling percentage was cal-
culated by determining the number of measurement sites 
that were filled with a red blood cell divided by 840 (total 
number of measurement sites). Volume was calculated by 
RBC filling % multiplied by vessel density (number of per-
fused vessels per observed muscle area).
To calculate the perfused boundary region (PBR), 
which is defined as the distance between the median 
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RBC column width and the estimated outer edge of the 
RBC column, the distribution of the RBC column width 
of each vascular segment is used (Fig.  1c). The cumula-
tive distribution curve of the RBC column widths was 
constructed and used to determine median RBC column 
diameter (DP50). The maximum RBC column width is 
extrapolated from the 25th and 75th percentile values 
of the RBC column width distribution curve. The PBR is 
considered to reflect glycocalyx thickness based on the 
assumption that loss of integrity of the glycocalyx allows 
for deeper penetration of erythrocytes into the vessel 
wall, resulting in increased PBR values [38].
Histological analysis
Paraffin-embedded hearts were sectioned in slices of 
5  µm. After rehydration the sections were stained with 
200 µl FITC-labeled lectin from triticum vulgaris (WGA-
FITC; 50 µg/ml, Sigma) for 30 min in the dark at room 
temperature (20  °C), washed three times with PBS and 
mounted with antifade mounting medium (ProLong 
Gold; Thermo Fisher Scientific). Cardiac tissue slices 
were visualised and photographed using a Leica DFC350 
FX digital camera (Leica, Rijswijk, The Netherlands) 
at 200× magnification with fixed exposure times and 
contrast settings (Leica DMI3000 microscope, Leica, 
Rijswijk, The Netherlands). Per animal, 5 pictures were 
analysed using Image J software. After defining a WGA-
FITC signal intensity threshold for the control chow-fed 
animals, 50 capillaries per picture were selected and the 
average capillary WGA signal intensity was calculated for 
each animal.
For the CD68 staining, paraffin-embedded heart sec-
tions were washed in increasing concentrations of etha-
nol followed by PBS. Sections were incubated overnight 
with 150 µl CD68 antibody (1 mg/ml; AbD Serotec), fol-
lowed by incubation with biotinylated Horse Anti-Mouse 
IgG Antibody, rat absorbed (HaM-RA; 0.5  mg/ml, Vec-
tor Labs) for 60 min. Sections were visualised using 0.5 % 
diaminobenzidine and 0.03 % hydrogen peroxidase, and 
counterstained with hematoxylin. The numbers of CD68-
stained cells were determined in 10 randomly selected 
fields (0.25 × 0.25 mm; 400×).
Fig. 1 Imaging of skeletal muscle microcirculation. a Example of a single SDF image of rat gastrocnemius microcirculation. b, In each microves-
sel that fitted the criteria of analysis (a) in focus, b) had a sufficient length and were not close to bifurcation, and c) were continuously filled with 
RBCs and did not contain plasma gaps) lines were placed ± every 10 µm perpendicular to the vessel direction (as shown by lines in image). c, 
Schematic illustration of the perfused boundary region (PBR) in relation to the glycocalyx barrier properties in a blood vessel. The PBR covers the 
cell-permeable part of the glycocalyx, to which RBCs have limited access, while the cell-impermeable part cannot be accessed at all. The PBR is the 
main readout parameter of the gastrocnemius SDF imaging, and calculated from the median RBC column width (P50) and outer diameter of RBC 
perfused lumen
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Heart cryosections, sectioned in slices of 7  µm, were 
air-dried and fixated in 4 %-saline buffered formaldehyde 
solution, followed by incubation with Oil-Red-O (Fluka; 
Sigma-Aldrich) for 30  min. Sections were washed three 
times with MilliQ and counterstained with hematoxylin.
Plasma lipid analysis
Cholesterol and triglyceride levels were measured in 
plasma samples of control and HFD rats. The enzymatic 
method to determine cholesterol level is based on the 
cleavage of cholesterol esters by cholesterol esterase to 
yield free cholesterol and fatty acids. Cholesterol oxidase 
then catalyzed the oxidation of cholesterol to cholest-4-
en-3-one and hydrogen peroxidase. In the presence of 
peroxidase, the hydrogen peroxide formed affected the 
oxidative coupling of phenol and 4-aminophenazone 
to form a red quinone-imine dye. The color intensity of 
the dye formed is directly proportional to the choles-
terol concentration and was determined by measuring 
the increase in absorbance (Cobas CHO2I and CHO2A, 
Roche Diagnostics, Mannheim, Germany).
The enzymatic triglyceride assay is based on using a 
lipoprotein lipase for the rapid and complete hydrolysis 
of triglycerides to glycerol followed by oxidation to dihy-
droxyacetone phosphate and hydrogen peroxide. The 
hydrogen peroxide produced then reacted with 4-ami-
nophenazone and 4-chlorophenol under the catalytic 
action of peroxidase and a red dye was formed. The color 
intensity of the red dye formed is directly proportional 
to the triglyceride concentration and was measured pho-
tometrically (Cobas TRIGL, Roche Diagnostics, Man-
nheim, Germany).
Gene expression analysis
Heart tissue fixated in Tissue-Tek (O.C.T. Compound) 
was sectioned in slices of 30  µm to collect tissue for 
RNA isolation. RLT buffer was added and heart tissue 
was homogenized. Total RNA was isolated from heart 
tissue using the RNeasy kit (Qiagen, Venlo, The Neth-
erlands) according to the manufacturer’s protocol. 
RNA integrity and concentration were checked by 
means of the 260 nm/280 nm ratio, and cDNA synthe-
sis was performed using 250 ng of RNA (Iscript cDNA 
synthesis kit, Biorad Inc., Hercules, CA, USA). Gene 
expression was analysed by quantitative PCR on an 
iCycler Real-Time PCR detection system using the iQ 
SYBR-green supermix (Biorad). The primer sequences 
are shown in Table  1. Results were normalized to the 
housekeeping gen cyclophilin-A, and relative changes 
in expression levels were calculated using the qBase 
analyser [37].
Statistical analysis
All data were presented as mean ± standard error of the 
mean (SEM). Statistical differences between the control 
group on normal chow and the HFD group were tested 
using an unpaired or paired sample t test, a repeated 
measurements analysis of variance (ANOVA) or a one-




Rats on the high-fat diet (HFD) for 6 weeks gained more 
body weight (+17 %, p = 0.002, Fig. 2a; Table 2) and had 
an almost threefold increase (p = 0.001) of the perirenal 
and epidydimal fat depots compared to chow-fed con-
trol animals. The HFD had no effect on blood pressure 
(Fig.  2b) and heart/body weight ratio (Table  2). Under 
non-fasting conditions, significant differences in blood 
glucose, plasma insulin (p  =  0.07) and triglyceride lev-
els were not observed between groups. Only the plasma 
total cholesterol level was higher (p < 0.001) in HFD rats 
compared to control rats.
Table 1 Gene-specific primer sequences used for quantitative real-time PCR
Gene Forward primer Reverse primer
α-Skeletal actin (αSKA) TGAGACCACCTACAACAGCA CCAGAGCTGTGATCTCCTTC
Angiopoietin-like 4 (Angptl4) CCTTTCCCTGCCCTTCTCTAC AGGCTCTTGGCACAGTTAAGG
Atrial natriuretic factor (ANF) AGCGAGCAGACCGATGAAGC GCAGAGTGGGAGAGGTAAGGC
Cluster of differentiation 68 (CD68) TAATACGACTCACTATAGGG TAGAAGGCACAGTCGAGG
Cyclophilin-A (Cyclo) CAAATGCTGGACCAAACACAA TTCACCTTCCCAAAGACCACAT
Endothelial nitric oxide synthase (eNOS) TGCTGCCCGAGATATCTTCAGT GGCTGCCTTTTTCCAGTTGTTC
Intercellular adhesion molecule (ICAM) AAACGGGAGATGAATGGTACCTAC TGCACGTCCCTGGTGATACTC
Monocyte chemoattractant protein-1 (MCP1) ATGCAGTTAATGCCCCACTC TGCTGCTGGTGATTCTCTTG
Pyruvate dehydrogenase kinase 4 (PDK4) GCATTTCTACTCGGATGCTCATG CCAATGTGGCTTGGGTTTCC
Vascular adhesion molecule (VCAM) GGCTCGTACACCATCCGC CGGTTTTCGATTCACACTCGT
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In fasted rats, however, insulin levels were higher 
in HFD rats compared to control rats (0.76 ±  0.26 and 
0.16  ±  0.03  ng/ml, respectively, p  <  0.05). Nonethe-
less, significant differences between control and HFD 
rats were not observed during the insulin tolerance test 
(Fig.  3a).The insulin-induced phosphorylation of Akt 
in the cardiac muscle (Fig.  3b), gastrocnemius muscle 
(Fig. 3c) and soleus muscle (Fig. 3d) was sharply reduced 
in HFD rats compared to control rats (p = 0.02, p < 0.001 
and p = 0.001 respectively). The collective findings indi-
cate that feeding rats a HFD for a relatively short period 
already induced marked abdominal adiposity and early 
stage of insulin resistance, but no hypertension.
Cardiac function
Baseline cardiac function, as assessed by MRI, was 
comparable between HFD and control rats (Table  3). 
Adenosine infusion evoked a significant drop in heart rate 
and a rise in end-diastolic left ventricular (LV) volumes, 
resulting in an increased SV in both groups. Ejection frac-
tion (EF) was comparable for both groups under baseline 
conditions as well as after adenosine infusion. The change 
of LV volume as a function of time (dV/dt) during the 
cardiac cycle was not significantly different between the 
control and HFD rats for all cardiac cycle phases (Fig. 4). 
However, absolute dV/dt values during systole and dias-
tole tended to be increased for the HFD rats compared to 
control rats at baseline (p = 0.082), whereas no such effect 
was seen during adenosine infusion (p = 0.919).
In addition diastolic wall thickness of the LV free wall 
and the septum was not different between HFD rats and 
control rats (Table 3).
Myocardial microvascular perfusion
The effect of HFD on coronary microvascular perfu-
sion under baseline conditions and following adenosine 
infusion was assessed by contrast-enhanced first-pass 
MRI by calculating the relative upslope, obtained from 
the signal intensity-time curve of the LV cavity and the 
LV myocardium upon contrast Gadobutrol injection 
(Fig.  5a). In control rats adenosine induced a robust 
increase in the relative upslope of the signal intensity-
time curve (+40  %, p =  0.02), reflecting an increase in 
coronary microvascular perfusion (Fig.  5b). The adeno-
sine response was greatly reduced (+8  %) in rats on a 
HFD for 6 weeks. The blunted adenosine response in the 
myocardium of HFD rats appeared to be mainly due to 
an already increased perfusion at baseline (+32 % in HFD 
vs control), although this difference did not reach the 
level of statistical significance (p = 0.11).
Glycocalyx properties
As the cardiac microcirculation cannot be visualised 
directly in  vivo, the effect of HFD on microcirculatory 
Fig. 2 Body weight and systolic and diastolic blood pressure of the control and HFD group. a Body weight was significantly higher for rats feeding 
a HFD (n = 9, filled circles) for 6 weeks compared to control rats (n = 9, open circles). b Neither systolic (solid line) nor diastolic (dashed line) blood 
pressure was affected by HFD
Table 2 Characteristics after  6  weeks of  HFD versus  con-
trol rats on standard chow
Data are expressed as mean ± SEM
* p < 0.05. HFD, high fat diet. Heart weight, perirenal fat and epidydimal fat was 
determined in 4 control rats and 4 HFD rats (n = 8)
Control (N = 9) HFD (N = 9)
Body composition
 Body weight (g) 392.2 ± 6.9 459.1 ± 10.4*
 Heart weight (g) 1.08 ± 0.05 1.25 ± 0.06
 Heart weight/body weight (x1000) 2.67 ± 0.11 2.67 ± 0.20
 Perirenal fat (g) 3.40 ± 0.31 11.88 ± 1.41*
 Epidydimal fat (g) 2.83 ± 0.14 9.20 ± 1.09*
Blood/plasma characteristics
 Hematocrit (%) 51.5 ± 1.7 49.3 ± 0.8
 Blood glucose (mmol/l) 6.25 ± 0.05 5.58 ± 0.80
 Plasma insulin (ng/ml) 0.32 ± 0.05 0.55 ± 0.11
 Total cholesterol (mmol/l) 1.69 ± 0.07 2.24 ± 0.08*
 Triglycerides (mmol/l) 0.83 ± 0.13 0.81 ± 0.1
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properties was assessed by sidestream darkfield (SDF) 
imaging of the gastrocnemius muscle of the same ani-
mals. SDF imaging in combination with Glycocheck 
software allows determination of vessel density and the 
perfused boundary region (PBR), a functional measure 
of glycocalyx integrity [35]. In the gastrocnemius mus-
cle the percentage of perfused vessels (84 and 77 % for 
HFD and control rats) and number of perfused vessels 
(1012 ± 64 and 1020 ± 77; p = 0.93), their cumulative 
volume (arbitrary units: 84619 ± 689 and 89525 ± 714 
for HFD and control rats, p = 0.815), as well as the vol-
ume distribution for vessels ranging from 5 to 25 µm in 
diameter (Fig. 6a), did not differ between HFD and con-
trol rats. The PBR of rats receiving HFD amounted to 
1.58 ±  0.02 µm and was comparable to rats on normal 
chow (1.68 ± 0.09 µm, p = 0.34, Fig. 6b). The collective 
Fig. 3 Intravenous insulin tolerance test (IVITT) in control and HFD rats. a Glucose level was corrected for baseline glucose level and time indicates 
the time after glucose infusion. No differences in glucose levels were observed between control (n = 9) and HFD rats (n = 9). Ventricular tissues (b), 
gastrocnemius muscle (c) and soleus muscle (d) were isolated at t = 0 (baseline conditions), t = 5 and t = 30 min (n = 3 per time point) after the 
insulin injection. The ratio of pAkt to total Akt was measured in hearts of control rats (open bars) and HFD rats (filled bars). For both cardiac and skel-
etal muscle tissue, Akt phosphorylation was decreased in HFD rats at 5 an 30 min after insulin infusion. For the soleus muscle, Akt phosphorylation 
was only significantly decreased at 30 min after insulin infusion. For all isolated tissues, representative Western Blots are shown. Data are expressed 
as mean ± SEM, *p < 0.05 diet effect
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findings suggest that 6  weeks of HFD did not result in 
rarefaction or loss of glycocalyx integrity in skeletal 
muscle.
Next, the intensity of WGA-staining of the capillary 
glycocalyx was used to determine if the glycocalyx of the 
cardiac microcirculation was affected by the HFD. As a 
proof of concept, we first showed that intravenous appli-
cation of hyaluronidase, an enzyme known to degrade 
the glycocalyx [39], resulted in a clearly visibly reduction 
in capillary WGA-staining intensity (Fig.  7c). However, 
using automated software analysis differences in cardiac 
staining intensity between HFD and control rats were not 
detected (Fig. 7a, b, d), suggesting that the HFD did not 
compromise cardiac glycocalyx properties to a significant 
extent.
Cardiac remodeling
To explore if HFD led to cardiac hypertrophy, tis-
sue sections were stained with wheat germ agglutinin 
FITC-labeled lectin. Differences in cardiomyocyte size 
between control rats and HFD rats, however, were not 
observed. This finding is supported by the unaltered 
expression of cardiac hypertrophy markers like atrial 
natriuretic factor (ANF) and α-skeletal actin (αSKA) 
(Table  4). In line with the absence of changes in clus-
ter of differentiation 68 (CD68) mRNA expression, 
CD68 immunostaining revealed no significant increase 
of macrophage infiltration in heart tissue of rats on 
HFD (18  ±  6 vs 14  ±  6 CD68-stained cells per mm2 
LV tissue for HFD and control rats, p  =  0.66; images 
not shown). The expression levels of the inflammation 
marker monocyte chemoattractant protein-1 (MCP1) 
showed no significant upregulation in HFD rats com-
pared to control rats either. Oil-red-O staining showed 
no significant lipid accumulation in the myocardium of 
HFD rats relative to control rats (images not shown). 
Expression of angiopoietin-like protein 4 (Angptl4) was 
not affected, while pyruvate dehydrogenase kinase 4 
(PDK4) tended to increase (p = 0.11). The mRNA levels 
of the endothelial activation genes intercellular adhe-
sion molecule (ICAM), vascular adhesion molecule 
(VCAM), endothelial nitric oxide synthase (eNOS), 
were also unaltered in HFD rats compared to control 
rats (Table 4).
Discussion
In this study, we demonstrated that feeding rats a high fat 
diet for 6 weeks already leads to disturbances in coronary 
microcirculatory perfusion as determined by contrast 
enhanced first-pass perfusion MRI at baseline and after 
an adenosine challenge. Importantly, the HFD-induced 
changes in cardiac microcirculatory perfusion are associ-
ated with central obesity and an impaired cardiac insulin 
sensitivity, but not with hypertension or signs of cardiac 
remodeling. The collective findings suggest that changes 
in coronary microcirculatory function represent one of 
Table 3 Left ventricular geometry and  function deter-
mined by  cine MRI of  control rats and  rats on  HFD 
for 6 weeks
Data are expressed as mean ± SEM
HFD high fat diet, EDV end-diastolic volume, ESV end-systolic volume, SV stroke 











Heart rate (bpm) 341 ± 13 312 ± 26* 386 ± 7 320 ± 16*
EDV (µl) 320 ± 15 380 ± 23* 295 ± 21 353 ± 36*
ESV (µl) 104 ± 12 108 ± 22 79 ± 11 79 ± 14
SV (µl) 216 ± 14 271 ± 34* 216 ± 20 274 ± 36*
EF (%) 67 ± 3 70 ± 7 73 ± 4 76 ± 4
Wall thickness (mm)
 LV free wall 1.49 ± 0.29 1.64 ± 0.24
 Septum 1.58 ± 0.22 1.67 ± 0.21
Fig. 4 Cardiac cycle left ventricular dV/dt values for control and HFD 
rats. a First derivatives of LV volume with respect to time for control 
(n = 9, open bars) and HFD rats (n = 9, filled bars) are presented for 
nine phases of cardiac cycle during baseline conditions. b dV/dt 
values are presented for cardiac cycle during adenosine infusion. The 
negative dV/dt values correspond to systole and positive values cor-
respond to diastole. Data are expressed as mean ± SEM, differences 
in absolute dV/dt values for the cardiac cycle phase were tested with 
ANOVA; *p < 0.05
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the earliest obesity-related functional abnormalities in 
the cardiac muscle.
Diet‑induced obesity
Diet-induced obesity is associated with dyslipidemia, 
glucose intolerance and insulin resistance in rats [25, 40–
42]. In the present study, 6 weeks of HFD led to a marked 
increase in abdominal fat depots and a rise in serum total 
cholesterol levels, but not in a rise of serum triglyceride, 
insulin or glucose levels as measured under non-fasting 
conditions. After overnight fasting, however, insulin lev-
els were higher in the rats on a HFD compared to chow-
fed rats. Moreover, insulin signaling in the heart and 
skeletal muscle of HFD rats was already disturbed, as evi-
denced by the reduced insulin-mediated phosphorylation 
of Akt in these tissues. Protein Kinase B (PKB) or Akt is 
Fig. 5 Myocardial perfusion measurements with first-pass perfusion MR imaging. a Signal intensity-time curve of LV cavity and myocardium 
derived from the mean signal intensity within regions of interest (ROI) measured in an MR image of the heart. Relative upslope was determined 
by dividing maximal upslope of the myocardium by maximal upslope of the LV cavity. b Semi-quantitative myocardial perfusion values (relative 
upslope) in LV myocardium of control rats (n = 9) and rats on HFD (n = 9) were presented during baseline conditions and adenosine infusion. Data 
are expressed as mean ± SEM, *p < 0.05 adenosine effect
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an important signaling protein in the intracellular insu-
lin pathway. In myocytes, phosphorylation of Akt (pAkt) 
triggers translocation of the glucose transporter GLUT4 
to the sarcolemma, which enables glucose to enter the 
myocytes [43]. Reduced insulin-mediated Akt phospho-
rylation reflects impaired signaling downstream of the 
insulin receptor and, thus, reduced insulin sensitivity of 
the cardiac muscle [44, 45].
Fig. 6 Imaging of the gastrocnemius muscle microcirculation to measure glycocalyx barrier properties. a Volume was determined for all vessel 
diameters (5–25 µm) for control rats (n = 9) and HFD rats (n = 9) and are not significantly different (p = 0.82). b No significant differences are found 
between the PBR of control rats (1.68 ± 0.09) and HFD rats (1.58 ± 0.02). Data are expressed as mean ± SEM, *p < 0.05
Fig. 7 Evaluation of cardiac myocyte size and signal intensity in control and HFD rats. A wheat germ agglutinin (WGA) FITC-labeled lectin staining 
was performed on heart tissue of control rats and HFD rats (a), The intensity of WGA-staining was measured in control rats (n = 4) and in HFD rats 
(n = 4; b). c As a positive control, cardiac tissue from hyaluronidase-treated rats was used, a clearly visible reduction in capillary WGA-staining inten-
sity was shown. d Cardiac staining intensity did not differ between control and HFD rats
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Cardiac function and cardiac remodeling
In the present study, 6  weeks of HFD feeding was not 
associated with marked changes in cardiac function. At 
baseline, the ejection fraction was comparable between 
HFD and control rats, suggesting that systolic function 
was not compromised. Moreover, adenosine infusion 
led to a comparable decrease in heart rate and increase 
in end-diastolic LV volume in control and HFD rats. 
Intriguingly, at baseline the rate of LV volume change 
across the cardiac cycle (dV/dt) tended to be increased 
for HFD rats in both systole and diastole suggesting that, 
if anything, baseline cardiac function is enhanced, rather 
than reduced, after 6 weeks of HFD. In literature incon-
sistent findings have been reported as far as the effect of 
HFD on myocardial function is concerned, with some 
studies reporting reduced function [25, 46], unchanged 
function [42] and improved function [21], respectively. 
In this context it is of note that one study reported that 
functional outcome was dependent on the exact compo-
sition of the HFD diet [42].
In the current study the HFD did not affect blood pres-
sure as measured in awake animals. Furthermore, there 
were no indications for HFD-induced cardiac remod-
eling. HFD for 6  weeks did not induce cardiac hyper-
trophy as assessed by heart weight to body weight ratio, 
LV wall thickness, cardiomyocyte size and expression of 
hypertrophic marker genes. Accordingly, the collective 
findings indicate that the observed changes in coronary 
microvascular perfusion in HFD rats cannot be explained 
by HFD-induced changes in blood pressure, cardiac 
function and cardiac remodeling.
Myocardial microvascular perfusion
In the present study we used first-pass contrast-enhanced 
MRI to assess the effects of diet on the coronary micro-
circulation. In chow-fed rats adenosine resulted in a 
robust  >40  % rise in coronary perfusion as assessed by 
the normalized relative upslope of the signal-time curve, 
reflecting an adequate hyperaemic response. In con-
trast, in the myocardium of rats fed a HFD for 6 weeks 
the hyperaemic response was completely blunted. 
The absence of the hyperaemic response in the myo-
cardium of HFD rats appeared to be due largely to an 
already increased coronary perfusion at baseline. Oth-
ers reported that coronary flow reserve (CFR) in rats 
was not affected at all after 4  weeks of HFD [25]. In 
mice, long-term HFD feeding (24  weeks) was associ-
ated with a reduction in CFR [22]. Likewise, a reduction 
in CFR was observed in patients with established type 2 
diabetes, but not in insulin resistant patients [23]. Oth-
ers reported a decline in CFR in obese, insulin resistant 
patients [19, 24], which was largely explained by concur-
rent hypertension-related increases in basal myocardial 
blood flow [19]. Indeed, baseline myocardial blood flow 
was similar in healthy controls and diabetic patients 
without hypertension [47]. In obesity-prone pigs feed-
ing a HFD for 10 weeks did not affect blood pressure and 
basal myocardial flow. After 14  weeks, however, when 
insulin resistance was established, basal myocardial flow 
was increased, presumably in response to an increased 
systolic function [48].
As reported above, in the present study, the HFD was 
not associated with a rise in blood pressure, exclud-
ing hypertension as a cause for the increase in baseline 
coronary perfusion. Although at baseline heart rate was 
slightly higher in HFD rats than in control rats (+13 %, 
Table 3), the difference in coronary perfusion at baseline 
was much more pronounced (+32 %), implying that the 
difference in cardiac work cannot explain the increased 
coronary perfusion in HFD rats at baseline.
In theory, HFD-induced endothelial dysfunction due 
to endothelial activation, increased microvascular per-
meability, or glycocalyx damage may account for the 
observed perfusion defects [24, 49]. Using tracer dilu-
tion techniques, we recently demonstrated that in mice 
suffering from severe diabetes the endothelial glycoca-
lyx was compromised at the systemic level [50]. In the 
present study, however, signs of endothelial activation 
or HFD-mediated inflammation were not found, as the 
expression of endothelial activation markers (ICAM, 
VCAM) remained constant and influx of inflammatory 
Table 4 Cardiac expression levels of  genes involved 
in  endothelial activation, inflammation, metabo-
lism and  cardiac hypertrophy in  control and  HFD rats 
after 6 weeks of high fat diet feeding
Data are expressed relative to control rats (chow) as mean ± SEM
* p < 0.05
Control (N = 8) HFD (N = 9) P value
Endothelial activation
 ICAM 1.0 ± 0.19 0.67 ± 0.13 0.13
 VCAM 1.0 ± 0.22 0.79 ± 0.14 0.43
 eNOS 1.0 ± 0.17 0.86 ± 0.14 0.52
Inflammation
 MCP1 1.0 ± 0.26 1.08 ± 0.41 0.88
 CD68 1.0 ± 0.25 0.65 ± 0.07 0.17
Metabolism
 PDK4 1.0 ± 0.17 1.94 ± 0.51 0.11
 Angptl4 1.0 ± 0.35 1.13 ± 0.31 0.79
Hypertrophy
 ANF 1.0 ± 0.39 0.45 ± 0.26 0.25
 αSKA 1.0 ± 0.24 1.36 ± 0.42 0.49
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cells in the myocardium was not observed. In line with 
this, coronary arteriolar vasomotor activity was found to 
be enhanced in rats on a HFD [20, 21], suggesting that 
endothelial function is not compromised under these 
conditions. Even in rat models of established diabetes 
(Zucker Diabetic rats) no signs of coronary endothelial 
dysfunction were observed [51].
It was previously shown that hyperlipidemia induces 
degradation of the glycocalyx and increases vascular wall 
adhesiveness [52]. As damage to the cardiac endothe-
lial glycocalyx cannot be measured directly, possible 
systemic effects of HFD on glycocalyx barrier proper-
ties were measured by visualising the microcirculation 
of the gastrocnemius muscle by means of SDF imag-
ing, which allows estimation of the so-called perfused 
boundary region (PBR). The PBR is considered to reflect 
glycocalyx integrity and is based on the notion that loss 
of glycocalyx allows for deeper penetration of erythro-
cytes into the endothelial lining, resulting in higher PBR 
values [38]. In an earlier study on impairment of skel-
etal muscle endothelial glycocalyx barrier properties in 
diet-induced obesity in mice, it was shown that the PBR 
in the skeletal muscle microcirculation was significantly 
increased 6  weeks after HFD already [13]. The present 
findings indicate that PBR was not (yet) affected in rats 
after 6 weeks of HFD. The difference in glycocalyx barrier 
properties observed between the two studies can possi-
bly be explained by the level of insulin resistance that is 
attained by the HFD in rats and mice. In contrast to the 
present study, Eskens et  al. [13] observed a marked rise 
in plasma glucose and insulin levels in mice in response 
to HFD, indicative of established insulin resistance. In 
the current study, however, we observed no differences 
in plasma levels, although the reduced insulin-stimulated 
AKT phosphorylation in muscle points to an already 
impaired insulin sensitivity.
Theoretically, changes in PBR can be masked by micro-
vascular rarefaction. However, the absence of changes in 
total vessel volume and in vessel diameter distribution 
argue against such a masking effect. Assuming that the 
glycocalyx properties of the gastrocnemius muscle are 
representative for the cardiac muscle, it must be con-
cluded that damage to the glycocalyx of the coronary 
endothelium cannot explain the HFD-induced change in 
coronary microvascular perfusion. However, it remains 
to be determined if the gastrocnemius microcirculation 
is a good proxy for the cardiac microcirculation when 
it comes to glycocalyx function as, unlike the heart, the 
gastrocnemius muscle is inactive during the SDF meas-
urements, contains both white and red muscle fibers, and 
produces energy by both aerobic and anaerobic metabo-
lism [53]. Nonetheless, the absence of significant differ-
ences in capillary WGA-staining intensity in cardiac 
histological sections supports the contention that the gly-
cocalyx of the coronary microcirculation was not dam-
aged to a significant extent in rats fed a HFD for 6 weeks.
Alternatively, the increase in baseline myocardial per-
fusion in rats on a HFD can possibly be explained by a 
shift of myocardial substrate use towards an increase in 
fatty acid (FA) oxidation. Normally 60–70 % of the energy 
needs of the beating heart are covered by the oxidation 
of FA, whereas carbohydrates (mainly glucose) account 
for the remaining 30–40 % [54–56]. In diabetes, cardiac 
glucose utilization is minimal, and energy production 
is shifted almost exclusively towards the oxidation of 
fatty acids (FA) [54]. Since cardiac insulin sensitivity is 
decreased in the HFD rats, the heart will become even 
more dependent on the oxidation of FA [54]. As the oxi-
dation of FA requires more oxygen than glucose (lower 
ATP/O ratio), cardiac efficiency (ratio of cardiac work 
to myocardial oxygen consumption) will decrease under 
these conditions [57]. This would fit with the observa-
tion that hemoglobin saturation, as assessed by Blood 
Oxygen Level-Dependent (BOLD) MRI, was decreased in 
the myocardium of obese, insulin resistant pigs [48, 58]. 
Thus, it is well conceivable that in diet-induced obese rats 
the myocardium may compensate for this diminished 
cardiac efficiency by increasing basal myocardial per-
fusion, thereby already consuming part of its coronary 
flow reserve capacity. However, further studies are war-
ranted to establish a direct link between cardiac substrate 
metabolism and coronary flow reserve in the (pre-)dia-
betic heart.
Conclusions
In conclusion, the present data demonstrate that changes 
in coronary microvascular perfusion as assessed by first-
pass perfusion MRI represent one of the earliest cardiac 
adaptations that can be assessed non-invasively in diet-
induced obesity. At this stage glycocalyx barrier proper-
ties in the gastrocnemius muscle were not affected as a 
consequence of the HFD challenge. The diet-induced 
changes in coronary microvascular perfusion occur at a 
time when cardiac insulin sensitivity gets compromised, 
but prior to the development of hypertension and cardiac 
remodeling, which are commonly associated with more 
advanced insulin resistance and type 2 diabetes. First-
pass perfusion MRI may represent a valuable diagnostic 
tool for the early detection of cardiac microvascular per-
fusion abnormalities in obese, insulin resistant persons, 
and in patients with non-ischemic heart disease.
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